Breath-Hold Does Not Improve Robotic Bronchoscopy Yield: STABLE Trial Roshen Mathew, MD, DAABIP

Published Date: 08 Nov 2026

Among 117 patients, breath-hold ventilation did not improve strict diagnostic yield vs conventional (86.8% vs 92.2%) in robotic bronchoscopy.

Read Full News

Latest News

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

7 Pulmonology Headlines You Missed in October

Todays Updates

Elizabeth Spurgeon, MD, on Lifestyle Interventions as an Adjunct to Epilepsy Care Isabella Ciccone, MPH, Elizabeth Spurgeon, MD

An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.

Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD

Todays Updates

Elizabeth Spurgeon, MD, on Lifestyle Interventions as an Adjunct to Epilepsy Care Isabella Ciccone, MPH, Elizabeth Spurgeon, MD

An epileptologist at Cleveland Clinic discussed findings from a recently published study of lifestyle interventions in epilepsy and why these approaches should complement rather than replace antiseizure medications.

Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD

Latest News

In a post hoc analysis of 2 phase 3 trials, AD109 reduced hypoxic burden by 69.8% vs 20.0% with placebo in postmenopausal women with OSA.

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

7 Pulmonology Headlines You Missed in October

News All Time

Depemokimab Year 1 Remission Linked to Better Year 2 Asthma Outcomes Michael Wechsler, MD, MSc

Michael Wechsler, MD, reports 59% of patients in clinical remission with twice-yearly depemokimab at year 1 maintained it at year 2 in SWIFT/AGILE.

HCPLive Five at CHEST 2026

Experts Discuss PAH Treatment Selection and Access

Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA Frank C. Sciurba, MD

Frank Sciurba, MD, reports tozorakimab improved E-RS:COPD scores vs placebo at week 52 in OBERON and TITANIA, including breathlessness and chest symptoms.

Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

At CHEST 2026, Pettigrew reviewed STRATIFY and STORM-PE data, citing bleeding risk with low-dose alteplase and 90-day walk gains with thrombectomy.

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Gabor Kovacs, MD, PhD, discusses phase 2a INSIGNIA PH-COPD results for inhaled frespaciguat presented at CHEST 2026.

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

Henrik Watz, MD, discusses 104-week OBERON, TITANIA, and PROSPERO data on tozorakimab in COPD presented at CHEST 2026.

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

At CHEST 2026, Jean Bourbeau, MD, said AI may support COPD diagnosis, remote monitoring, and posthospital care, though most tools still need validation.

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Inside The New AHA/ACC Acute Pulmonary Embolism Categories

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

Anjali Vaidya, MD, explains why echocardiography should inform right heart catheterization interpretation in pulmonary hypertension at CHEST 2026.

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

Samantha Pettigrew, MD, reviews HI-PEITHO, PRAGUE-26, and PEERLESS and how they shape intervention choices in intermediate-risk PE at CHEST 2026.

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

At CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.

combating racial discrimination in next-generation breast cancer screening.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

Participate and win cash vouchers

Get updates on the latest events happening around the world

2.

The pathology of incurable cancers can be predicted thanks to research.

3.

Cancer Patients' Depression May Be Helped by Psilocybin.

4.

Clinical trial sees dramatic results using radiation to treat breast cancer

5.

Cancerous breast tissue glows in new AI-enhanced MRI images

1.

Adaptive Neoantigen Vaccines for Solid Tumor Therapy

2.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

3.

Integrated Frameworks in Hematology in Clinical Decision-Making

4.

Advancing Oncology Careers with Education, Workflow Tools, and Clinical Resources

5.

Unraveling the Genetic Mystery of Hereditary Spherocytosis

1.

International Conference on Innovations in Critical Care for Oncology and Cardiology

2.

International Conference on Oncology, Cardiology and Critical Care Policy

3.

International Conference on Oncology, Cancer Prevention and Public Health

4.

International Conference on Cancer Nursing and Rehabilitation Strategies

5.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

1.

Thromboprophylaxis In Medical Settings

2.

From Guidelines to Practice: Hematology

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

5.

Sickle Cell Disease Explained

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Breath-Hold Does Not Improve Robotic Bronchoscopy Yield: STABLE Trial Roshen Mathew, MD, DAABIP

Latest News

AD109 Cuts AHI by 59.6% in Postmenopausal Women With OSA Reena Mehra, MD

Q&A: Why IL-33 Matters for Mucus Plugs, Inflammation in COPD

2027 GOLD Report Update Preview: Changes in COPD Treatment, Biologics

Mucus Plug Reduction with Type 2 Biologics: Lessons for COPD

Nasal mRNA ETH47 Lowers Rhinovirus Load in Asthma Challenge Study

7 Pulmonology Headlines You Missed in October

Todays Updates

Elizabeth Spurgeon, MD, on Lifestyle Interventions as an Adjunct to Epilepsy Care Isabella Ciccone, MPH, Elizabeth Spurgeon, MD

Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD

Todays Updates

Elizabeth Spurgeon, MD, on Lifestyle Interventions as an Adjunct to Epilepsy Care Isabella Ciccone, MPH, Elizabeth Spurgeon, MD

Biopsy Scarring and Pegcetacoplan Response in C3G, With Carla Nester, MD

Latest News

News All Time

Depemokimab Year 1 Remission Linked to Better Year 2 Asthma Outcomes Michael Wechsler, MD, MSc

HCPLive Five at CHEST 2026

Experts Discuss PAH Treatment Selection and Access

Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA Frank C. Sciurba, MD

Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD

Weighing Bleeding Risk in Pulmonary Embolism, With Samantha Pettigrew, MD Samantha Pettigrew, MD

Frespaciguat Misses 6MWD End Point in PH-COPD: Gabor Kovacs, MD, PhD Gabor Kovacs, MD, PhD

Tozorakimab Sustains COPD Exacerbation Benefit to 2 Years: Henrik Watz, MD Henrik Watz, MD, PhD

AI and Emerging Technologies in COPD Care, With Jean Bourbeau, MD Jean Bourbeau, MD

TPIP's Efficacy Holds as PALM-ILD Advances, With Colin Church, MBBS, PhD

TPIP Tolerable Over 2 Years in PH-ILD, With Colin Church, MBBS, PhD

Ralinepag's Benefit Spans Broad PAH Population, With Jean Elwing, MD

Inside The New AHA/ACC Acute Pulmonary Embolism Categories

Pair Echo With Right Heart Catheterization in PH: Anjali Vaidya, MD Anjali Vaidya, MD, FACC, FASE, FACP

New Trials Favor PE Intervention in Sicker Intermediate-Risk Patients Samantha Pettigrew, MD

Tailoring Pulmonary Rehab to Close the COPD Gap, With Omid Pourshahid, MD Omid Pourshahid, MD

Recommended News For You

Error on the MGUS-Autoimmune Disease Association.

Preschoolers With Cancer Have Poor Motor Skills

Investigations may result in novel combination therapies for early-stage lung cancers.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

Ruxolitinib Reduces Acute GVHD in Transplant Patients

combating racial discrimination in next-generation breast cancer screening.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

Recommended Articles For You

Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide

Structural Variant Landscapes in Solid Tumors: Clinical and Molecular Perspectives

Unlocking the Mystery of Granulomas: A Closer Look at the Causes and Treatment

Whats more on Hidoc Dr.

Medical Updates

KOL Videos

Surveys

Events

Featured News

Featured Articles

Featured Events

Featured KOL Videos

Quick Links

Verification

Welcome to Hidoc Dr.